MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Ballet for Parkinson’s disease, a new concept: Remote delivery via the English National Ballet’s Dance for Parkinson’s programme

    A. Podlewska, R. Davis, L. Batzu, P. Tall, F. Derbyshire-Fox, A. Hartley, N. Sevdalis, A. Woods, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To explore the characteristics and subjective outcomes for People with Parkinson’s (PwP) attending online Dance for Parkinson’s sessions professionally delivered by the English National…
  • 2022 International Congress

    Safety and tolerability of Nilotinib in patients with Huntington’s disease

    K. Anderson (Washington, USA)

    Objective: To investigate the safety and tolerability of nilotinib, an FDA-approved drug for leukemia, in individuals with Huntington’s disease (HD). Background: Previous clinical studies in…
  • 2022 International Congress

    Comorbid neuropathological features in multiple system atrophy

    H. Sekiya, S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

    Objective: To elucidate the distribution of comorbid neuropathology in multiple system atrophy (MSA) and its clinical correlation. Background: Multiple protein accumulations are often present in…
  • 2022 International Congress

    Administration of the mGlu2 positive allosteric modulator BINA as monotherapy improves parkinsonism in the MPTP-lesioned marmoset

    C. Kwan, A. Hamadjida, I. Frouni, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To assess the effect of selective metabotropic glutamate type 2 (mGlu2) receptor activation on parkinsonism as monotherapy in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset compared to…
  • 2022 International Congress

    Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022

    L. Castanheira, C. Lobo, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of the main sleep disorders in patients with Parkinson's disease at a referral outpatient clinic for movement disorders. Background: Parkinson's…
  • 2022 International Congress

    A Man Who Has Been Presenting with Pruritus and Myoclonus

    EJ. Choi, DG. Lee, AR. Lim (Gumi, Republic of Korea)

    Objective: While various neurological symptoms of sparganosis including have been reported, this is the first documented instance in which sparganosis presented with myoclonus. Background: Sparganosis…
  • 2022 International Congress

    DaTscan striatal binding ratio dynamics in mutations carriers at risk for Parkinson’s disease: A 2-year prospective study

    A. Droby, D. Atias, H. Lerman, RM. Hutchison, L. Yahimovich, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To investigate the temporal dynamics of striatal binding ratios (SBRs) among individuals with Parkinson's disease (PD)-related mutations and its' association with likelihood ratio (LR)…
  • 2022 International Congress

    Gait Characteristics from Daily Life Increase Ability to Predict Future Falls in People with Parkinson’s Disease

    V. Shah, J. Mcnames, G. Harker, P. Carlson-Kuhta, J. Nutt, M. El Gohary, K. Sowalsky,, M. Mancini, F. Horak (Portland, USA)

    Objective: We investigated if digital measures of different aspects of gait (walking and turning) from a week of daily activities increase discriminative ability to predict…
  • 2022 International Congress

    Anti-α-synuclein antibody 5G4 differentiates idiopathic REM Sleep Behavior Disorder patients from healthy controls in skin biopsies

    S. Toth, K. Kulcsarova, E. Feketeova, J. Ventosa, M. Maretta, A. Kunova, M. Bekeova, P. Christova, J. Baloghova, E. Mechírová, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of our study was to assess α-synuclein (α-syn) staining using the 5G4 antibody in skin samples of patients with idiopathic REM Sleep…
  • 2022 International Congress

    Gait analysis using Wearable Sensors: different gait metrics can differentiate Parkinson’s Disease Patients from Healthy Controls and Parkinson’s Disease patients in different medication status

    R. Barbosa, M. Medonça, R. Oliveira, M. Santos, A. Abreu, P. Bastos, P. Pita-Lobo, A. Valadas, L. Correia-Guedes, J. Ferreira, M. Rosa, R. Matias, M. Coelho (Lisbon, Portugal)

    Objective: To identify which gait metrics better distinguish PD-OFF from PD Best-ON and PD from HC, using a dimensionality-reduction method Background: Objective gait analysis using…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley